Clinical Gastroenterology and Hepatology
Volume 2, Issue 5 , Pages 389-394, May 2004

Predictors of outcome of pneumatic dilation in achalasia

  • Kaveh Farhoomand

      Affiliations

    • Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio, USA
  • ,
  • Jason T Connor

      Affiliations

    • Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio, USA
  • ,
  • Joel E Richter

      Affiliations

    • Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio, USA
  • ,
  • Edgar Achkar

      Affiliations

    • Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio, USA
  • ,
  • Michael F Vaezi

      Affiliations

    • Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • Corresponding Author InformationAddress requests for reprints to: Michael F. Vaezi, M.D., Ph.D., Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195 USA; fax: (216) 444-6302

Abstract 

Graded pneumatic dilation (PD) is a widely accepted treatment for achalasia. We investigated the potential predictors of outcome in a large group of patients with achalasia and tested the hypothesis that graded PD may not be appropriate for all patients. Patients undergoing PD from 1992 to 2002 were evaluated retrospectively. Symptom scores (0–15) for dysphagia (0–5), regurgitation (0–5), and chest pain (0–5), as well as degree of esophageal emptying by timed barium swallow, were assessed for all patients. Failure was defined as the return of symptoms resulting in repeated PD or surgical myotomy. Clinical data assessed for short- and long-term predictors of response. Seventy-five patients with achalasia without previous therapy constituted the studied population. Three-year success rates for PD using 3.0-cm, 3.0-cm followed by 3.5-cm, and 3.0-cm and 3.5-cm followed by 4.0-cm Rigiflex balloons were 37% (95% confidence interval [CI], 26–53), 76% (95% CI, 65–88), and 88% (95% CI, 80–97), respectively. Patient age and sex were important treatment outcome predictors. A Cox proportional hazards model of time to additional therapy on sex and 10-year increase in age showed that 3.0-cm PD was significantly (P = 0.04) more likely to fail in younger men than older men (hazard ratio, 0.63; 95% CI, 0.41–0.98). In 25 of 68 patients (37%) initially treated with a 3.0-cm balloon, PD failed within 3 months. Twenty-two of 25 patients (88%) with early failure were men. (1) Young men have a greater failure rate with 3.0-cm PD than older men or women in general, and (2) graded PD in this group starting initially with the 3.0-cm balloon is more likely to fail.

Abbreviations:  CI, confidence interval, LES, lower esophageal sphincter, PD, pneumatic dilation

 

PII: S1542-3565(04)00123-5

Clinical Gastroenterology and Hepatology
Volume 2, Issue 5 , Pages 389-394, May 2004